» Articles » PMID: 18541825

25-hydroxyvitamin D and Risk of Myocardial Infarction in Men: a Prospective Study

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2008 Jun 11
PMID 18541825
Citations 434
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D deficiency may be involved in the development of atherosclerosis and coronary heart disease in humans.

Methods: We assessed prospectively whether plasma 25-hydroxyvitamin D (25[OH]D) concentrations are associated with risk of coronary heart disease. A nested case-control study was conducted in 18,225 men in the Health Professionals Follow-up Study; the men were aged 40 to 75 years and were free of diagnosed cardiovascular disease at blood collection. The blood samples were returned between April 1, 1993, and November 30, 1999; 99% were received between April 1, 1993, and November 30, 1995. During 10 years of follow-up, 454 men developed nonfatal myocardial infarction or fatal coronary heart disease. Using risk set sampling, controls (n = 900) were selected in a 2:1 ratio and matched for age, date of blood collection, and smoking status.

Results: After adjustment for matched variables, men deficient in 25(OH)D (<or=15 ng/mL [to convert to nanomoles per liter, multiply by 2.496]) were at increased risk for MI compared with those considered to be sufficient in 25(OH)D (>or=30 ng/mL) (relative risk [RR], 2.42; 95% confidence interval [CI], 1.53-3.84; P < .001 for trend). After additional adjustment for family history of myocardial infarction, body mass index, alcohol consumption, physical activity, history of diabetes mellitus and hypertension, ethnicity, region, marine omega-3 intake, low- and high-density lipoprotein cholesterol levels, and triglyceride levels, this relationship remained significant (RR, 2.09; 95% CI, 1.24-3.54; P = .02 for trend). Even men with intermediate 25(OH)D levels were at elevated risk relative to those with sufficient 25(OH)D levels (22.6-29.9 ng/mL: RR, 1.60 [95% CI, 1.10-2.32]; and 15.0-22.5 ng/mL: RR, 1.43 [95% CI, 0.96-2.13], respectively).

Conclusion: Low levels of 25(OH)D are associated with higher risk of myocardial infarction in a graded manner, even after controlling for factors known to be associated with coronary artery disease.

Citing Articles

Association of Vitamin D Deficiency as an Independent Risk Factor for Myocardial Infarction and Its Therapeutic Implications: A Systematic Review.

Balasubramanian A, Kunchala K, Shahbaz A, Kar A, Sankar J, Anand S Cureus. 2025; 17(1):e77375.

PMID: 39944452 PMC: 11817865. DOI: 10.7759/cureus.77375.


Calcitriol Concentration in the Early Phase of Myocardial Infarction and Its Relation to Left Ventricular Ejection Fraction.

Oledzki S, Siennicka A, Maciejewska-Markiewicz D, Stachowska E, Jakubiak N, Kiedrowicz R Metabolites. 2024; 14(12).

PMID: 39728467 PMC: 11677622. DOI: 10.3390/metabo14120686.


The Co-Existence of Hypovitaminosis D and Diabetes Mellitus Triples the Incidence of Severe Coronary Artery Disease in Women.

Aleksova A, Janjusevic M, Pani B, Hiche C, Chicco A, Derin A J Clin Med. 2024; 13(22).

PMID: 39597936 PMC: 11594877. DOI: 10.3390/jcm13226792.


Effect of vitamin D supplementation on cardiovascular outcomes: an updated meta-analysis of RCTs.

Mirza A, Almansouri N, Muslim M, Basheer T, Uppalapati S, Lakra S Ann Med Surg (Lond). 2024; 86(11):6665-6672.

PMID: 39525782 PMC: 11543226. DOI: 10.1097/MS9.0000000000002458.


The Impact of Atorvastatin Treatment on the Distribution of Low-Density Lipoprotein Subfractions and the Level of Vitamin D in Patients After Acute Myocardial Infarction: Preliminary Findings.

Sygitowicz G, Sitkiewicz D, Wrzosek K, Dluzniewski M Int J Mol Sci. 2024; 25(20).

PMID: 39457047 PMC: 11508669. DOI: 10.3390/ijms252011264.


References
1.
Li Y, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J . Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):387-92. DOI: 10.1016/j.jsbmb.2004.03.004. View

2.
Rimm E, Giovannucci E, Willett W, Colditz G, Ascherio A, Rosner B . Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991; 338(8765):464-8. DOI: 10.1016/0140-6736(91)90542-w. View

3.
Krause R, Buhring M, Hopfenmuller W, Holick M, Sharma A . Ultraviolet B and blood pressure. Lancet. 1998; 352(9129):709-10. DOI: 10.1016/S0140-6736(05)60827-6. View

4.
Timms P, Mannan N, Hitman G, Noonan K, Mills P, Syndercombe-Court D . Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. QJM. 2002; 95(12):787-96. DOI: 10.1093/qjmed/95.12.787. View

5.
Platz E, Leitzmann M, Hollis B, Willett W, Giovannucci E . Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004; 15(3):255-65. DOI: 10.1023/B:CACO.0000024245.24880.8a. View